Pulse Biosciences, Inc.
PLSE
Rank in Stocks
#4283
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Share Price
$51.39
Last synced: 2026-10-21
Market Cap
$3.67B
Change (1 day)
1.09%
Change (1 year)
197.94%
Country
US
Trade Pulse Biosciences, Inc. (PLSE)
Category
Healthcare
Stock price history for Pulse Biosciences, Inc. (PLSE)
Highest end of day price: $49.20 on 2026-10-01
Lowest end of day price: $4.20 on 2016-05-01
Lowest end of day price: $4.20 on 2016-05-01
Stock price history of Pulse Biosciences, Inc. from 2016 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 90.82% |
| 2025 | -23.80% |
| 2024 | 72.60% |
| 2023 | 322.28% |
| 2022 | -84.88% |
| 2021 | -15.48% |
| 2020 | 41.40% |
| 2019 | 19.04% |
| 2018 | -50.17% |
| 2017 | 306.74% |
| 2016 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $431.34 | -18.16% |
US
|
|
| $195.69 | -45.89% |
FR
|
|
| $170.48 | 12.48% |
JP
|
|
| $194.26 | 31.35% |
US
|
|
| $67.71 | -11.53% |
CH
|
